Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

O-1812

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
O-1812
Identifiers
  • (5Z,8Z,11Z,14Z)-20-cyano-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethylicosa-5,8,11,14-tetraenamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC26H42N2O2
Molar mass414.634 g·mol−1
3D model (JSmol)
  • C[C@H](CO)NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C(C)(C)CCCCC#N
  • InChI=1S/C26H42N2O2/c1-24(23-29)28-25(30)19-15-12-10-8-6-4-5-7-9-11-13-16-20-26(2,3)21-17-14-18-22-27/h4-5,8-11,16,20,24,29H,6-7,12-15,17-19,21,23H2,1-3H3,(H,28,30)/b5-4-,10-8-,11-9-,20-16-/t24-/m1/s1 ☒N
  • Key:WZQHSBKOWZOASP-QLZKPENWSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

O-1812 is aneicosanoid derivative related toanandamide that acts as a potent and highly selectiveagonist for thecannabinoid receptorCB1, with aKi of 3.4 nM at CB1 and 3870 nM atCB2.[1] Unlike most related compounds, O-1812 is metabolically stable against rapid breakdown by enzymes, and produces a cannabinoid-like discriminative effect in rats, which is similar but not identical to that produced by cannabinoid drugs of other chemical classes.[2][3][4][5]

See also

[edit]

References

[edit]
  1. ^Di Marzo V, et al. (February 2001). "Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands".Biochemical and Biophysical Research Communications.281 (2):444–51.doi:10.1006/bbrc.2001.4354.PMID 11181068.
  2. ^Baskfield CY, Martin BR, Wiley JL (April 2004). "Differential effects of Δ9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice".The Journal of Pharmacology and Experimental Therapeutics.309 (1):86–91.doi:10.1124/jpet.103.055376.PMID 14718593.S2CID 36621393.
  3. ^Wiley JL, et al. (August 2004). "A comparison of the discriminative stimulus effects of Δ9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats".Experimental and Clinical Psychopharmacology.12 (3):173–9.doi:10.1037/1064-1297.12.3.173.PMID 15301634.
  4. ^Wiley JL, Smith FL, Razdan RK, Dewey WL (March 2005). "Task specificity of cross-tolerance between Δ9-tetrahydrocannabinol and anandamide analogs in mice".European Journal of Pharmacology.510 (1–2):59–68.doi:10.1016/j.ejphar.2005.01.006.PMID 15740725.
  5. ^Breivogel CS, et al. (July 2008)."Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in β-arrestin2 -/- mice".Behavioural Pharmacology.19 (4):298–307.doi:10.1097/FBP.0b013e328308f1e6.PMC 2751575.PMID 18622177.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)


Stub icon

This article about analkene is astub. You can help Wikipedia byexpanding it.

Stub icon

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=O-1812&oldid=1268767723"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp